Adiponectin, therefore, promotes fat storage in AT and increases insulin sensitivity, with its decrease in obesity a causal factor in insulin resistance, lipotoxicity, and metabolic syndrome manifestations (92). Here, ADIPOQ is linked to obesity disorder.